Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis

被引:129
|
作者
Schlüter, B
Raufhake, C
Erren, M
Schotte, H
Kipp, F
Rust, S
Van Aken, H
Assmann, G
Berendes, E
机构
[1] Univ Hosp Munster, Inst Clin Chem & Lab Med, D-48129 Munster, Germany
[2] Univ Hosp Munster, Dept Anesthesiol & Operat Intens Care Med, D-48129 Munster, Germany
[3] Univ Hosp Munster, Dept Internal Med, D-48129 Munster, Germany
[4] Univ Hosp Munster, Inst Med Microbiol, D-48129 Munster, Germany
关键词
interleukin-6; cytokines; sepsis; critical care; inflammation mediators; patient outcome assessment; immunogenetics; genetic markers; single nucleotide polymorphism; polymerase chain reaction;
D O I
10.1097/00003246-200201000-00005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: A biallelic polymorphism within the human interleukin (IL)-6 gene promoter region (-174 G/C) has been shown to affect IL-6 transcription in vitro and IL-6 plasma levels in healthy adults. Because IL-6 is excessively released into the circulation during sepsis and closely correlates with the clinical course, we studied whether this promoter polymorphism has an effect on the incidence and/or outcome of sepsis. Design: Population-based association study in critically ill patients and healthy controls. Setting: Surgical intensive care unit (ICU) in a German university hospital. Patients: Surgical patients (n = 326) of German Caucasian origin with an ICU stay of at least 3 days admitted between 1997 and 1999 were prospectively enrolled. In a subset of 50 patients, sepsis was diagnosed according to consensus criteria (American College of Chest Physicians 1992). Healthy sex-matched adults of the same ethnic and geographic background served as controls. Interventions: Blood sampling. Measurements and Main Results: The (-174 G/C) polymorphism was genotyped by an allele-specific polymerase chain reaction. IL-6 plasma levels were determined by enzyme-linked immunosorbent assay. Genotype distribution and allele frequencies did not differ significantly between patients with or without sepsis and healthy controls. In patients who finally succumbed to sepsis, significantly less GG homozygotes were observed compared with survivors (p = .008). Median systemic IL-6 levels in septic patients closely correlated with outcome (p < .0001) but were not associated with the IL-6 promoter genotype, Conclusions: The IL-6 promoter polymorphism (-174 G/C) does not affect the incidence of sepsis. However, the GG homozygous genotype is significantly associated with an improved survival in sepsis. Because this association is independent from the systemic IL-6 response, we suggest that other genetically linked polymorphisms may be the primary cause.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 50 条
  • [1] Effect of the interleukin-6 (-174) G/C promoter polymorphism on adiponectin and insulin sensitivity
    Yang, XL
    Jansson, PA
    Pellmé, F
    Laakso, M
    Smith, U
    OBESITY RESEARCH, 2005, 13 (05): : 813 - 817
  • [2] Influence of Interleukin-6 Promoter Polymorphism-174 G/C on Kidney Graft Outcome
    Sanchez-Velasco, P.
    Rodrigo, E.
    Fernandez-Fresnedo, G.
    Ocejo-Vinyals, J. G.
    Ruiz, J. C.
    Arnau, A.
    Leyva-Cobian, F.
    Arias, M.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 2854 - 2855
  • [3] Effect of an interleukin-6 promoter polymorphism on susceptibility to sepsis and sepsis outcome in surgical patients
    Schlüter, B
    Raufhake, C
    Driller, B
    Berendes, E
    Schotte, H
    Maseizik, T
    Reith, HB
    Rust, S
    Erren, M
    5TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS: PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2000, : 863 - 867
  • [4] Promoter region polymorphism (-174 G/C) of interleukin-6 gene and SLE; are they associated?
    Abbas, Doaa
    Hamdy, Enas
    Helal, Manal Mahmoud
    EGYPTIAN RHEUMATOLOGIST, 2011, 33 (02): : 69 - 75
  • [5] Association of interleukin-6 promoter polymorphism (-174 G/C) with systemic lupus erythematosus
    Li, Ruo-Jie
    Pan, Hai-Feng
    Wang, Chao
    Ye, Dong-Qing
    CLINICAL RHEUMATOLOGY, 2011, 30 (06) : 867 - 868
  • [6] Association of interleukin-6 promoter polymorphism (−174 G/C) with systemic lupus erythematosus
    Ruo-Jie Li
    Hai-Feng Pan
    Chao Wang
    Dong-Qing Ye
    Clinical Rheumatology, 2011, 30 : 867 - 868
  • [7] Associations of the −174 G/C Interleukin-6 Gene Promoter Polymorphism with Serum Interleukin 6 and Mortality in the Elderly
    Giovanni Ravaglia
    Paola Forti
    Fabiola Maioli
    Martina Chiappelli
    Paolo Dolzani
    Mabel Martelli
    Marisa Bianchin
    Erminia Mariani
    Luigi Bolondi
    Federico Licastro
    Biogerontology, 2005, 6 : 415 - 423
  • [8] -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race
    Mandal, S.
    Abebe, F.
    Chaudhary, J.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (01) : 139 - 151
  • [9] The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans
    Endler, G
    Marsik, C
    Joukhadar, C
    Marculescu, R
    Mayr, F
    Mannhalter, C
    Wagner, OF
    Jilma, B
    CLINICAL CHEMISTRY, 2004, 50 (01) : 195 - 200
  • [10] C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance
    Cardellini, M
    Perego, L
    D'Adamo, M
    Marini, MA
    Procopio, C
    Hribal, ML
    Andreozzi, F
    Frontoni, S
    Giacomelli, M
    Paganelli, M
    Pontiroli, AE
    Lauro, R
    Folli, F
    Sesti, G
    DIABETES CARE, 2005, 28 (08) : 2007 - 2012